Cargando…
Phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers
New antibiotics are urgently needed to reduce the health burden of antibiotic-resistant bacterial infection. Natural products (NPs) derived from plants and animals are a current focus of research seeking to discover new antibacterial molecules with clinical potential. A cocktail of NPs based on a me...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667429/ https://www.ncbi.nlm.nih.gov/pubmed/36385621 http://dx.doi.org/10.1038/s41598-022-22700-4 |
_version_ | 1784831722268917760 |
---|---|
author | Bruce, Julie Oyedemi, Blessing Parsons, Nick Harrison, Freya |
author_facet | Bruce, Julie Oyedemi, Blessing Parsons, Nick Harrison, Freya |
author_sort | Bruce, Julie |
collection | PubMed |
description | New antibiotics are urgently needed to reduce the health burden of antibiotic-resistant bacterial infection. Natural products (NPs) derived from plants and animals are a current focus of research seeking to discover new antibacterial molecules with clinical potential. A cocktail of NPs based on a medieval remedy for eye infection eliminated biofilms of several highly antibiotic-resistant bacterial species in laboratory studies, and had a promising safety profile in vitro and in a mouse model. A necessary prelude to refining this remedy into a defined, synthetic mixture suitable for testing with wound infections is to firstly establish safety when applied to healthy human skin. We aimed to assess skin-related outcomes of the preparation in a sample of healthy volunteers. This prospective, single arm, non-randomised Phase I clinical trial consisted of a single patch test intervention with 48-h follow-up. Volunteers were staff, students and members of the public recruited from the University of Warwick and surrounding locality. Adults aged 18–79 years, with no history of severe immunity-related disease, diabetes, recent infection, or known pregnancy were eligible. A 100 µl application of a filter-sterilised NP mixture, comprising ground garlic, onion, white wine and bovine bile, was applied to skin on the upper arm and covered with a dressing. The primary outcome was skin-related adverse events over 48 h. Digital photographs were captured where bothersome, salve-related events were reported. 109 volunteers, aged 18–77 years, were recruited between June and July 2021. Sample mean age was 37.6 (SD 16.1) years, and 63 (58%) participants were female. Outcome data were obtained for 106/109 (97%); two participants were lost to follow-up and one removed the skin patch after nine hours due to a bothersome garlic odour. Twenty-one (19.8%) participants reported any patch-test related sign or symptom; of these 14 (13.2%) participants reported minor events related to the salve, including itchiness, redness, or garlic odour. No serious events were reported. We found no evidence of serious skin-related adverse events related to the NP preparation. Trial registration: International Standard Randomised Controlled Trial Number (ISRCTN10773579). Date registered: 08/01/2021. |
format | Online Article Text |
id | pubmed-9667429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96674292022-11-16 Phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers Bruce, Julie Oyedemi, Blessing Parsons, Nick Harrison, Freya Sci Rep Article New antibiotics are urgently needed to reduce the health burden of antibiotic-resistant bacterial infection. Natural products (NPs) derived from plants and animals are a current focus of research seeking to discover new antibacterial molecules with clinical potential. A cocktail of NPs based on a medieval remedy for eye infection eliminated biofilms of several highly antibiotic-resistant bacterial species in laboratory studies, and had a promising safety profile in vitro and in a mouse model. A necessary prelude to refining this remedy into a defined, synthetic mixture suitable for testing with wound infections is to firstly establish safety when applied to healthy human skin. We aimed to assess skin-related outcomes of the preparation in a sample of healthy volunteers. This prospective, single arm, non-randomised Phase I clinical trial consisted of a single patch test intervention with 48-h follow-up. Volunteers were staff, students and members of the public recruited from the University of Warwick and surrounding locality. Adults aged 18–79 years, with no history of severe immunity-related disease, diabetes, recent infection, or known pregnancy were eligible. A 100 µl application of a filter-sterilised NP mixture, comprising ground garlic, onion, white wine and bovine bile, was applied to skin on the upper arm and covered with a dressing. The primary outcome was skin-related adverse events over 48 h. Digital photographs were captured where bothersome, salve-related events were reported. 109 volunteers, aged 18–77 years, were recruited between June and July 2021. Sample mean age was 37.6 (SD 16.1) years, and 63 (58%) participants were female. Outcome data were obtained for 106/109 (97%); two participants were lost to follow-up and one removed the skin patch after nine hours due to a bothersome garlic odour. Twenty-one (19.8%) participants reported any patch-test related sign or symptom; of these 14 (13.2%) participants reported minor events related to the salve, including itchiness, redness, or garlic odour. No serious events were reported. We found no evidence of serious skin-related adverse events related to the NP preparation. Trial registration: International Standard Randomised Controlled Trial Number (ISRCTN10773579). Date registered: 08/01/2021. Nature Publishing Group UK 2022-11-16 /pmc/articles/PMC9667429/ /pubmed/36385621 http://dx.doi.org/10.1038/s41598-022-22700-4 Text en © Crown 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Bruce, Julie Oyedemi, Blessing Parsons, Nick Harrison, Freya Phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers |
title | Phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers |
title_full | Phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers |
title_fullStr | Phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers |
title_full_unstemmed | Phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers |
title_short | Phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers |
title_sort | phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667429/ https://www.ncbi.nlm.nih.gov/pubmed/36385621 http://dx.doi.org/10.1038/s41598-022-22700-4 |
work_keys_str_mv | AT brucejulie phase1safetytrialofanaturalproductcocktailwithantibacterialactivityinhumanvolunteers AT oyedemiblessing phase1safetytrialofanaturalproductcocktailwithantibacterialactivityinhumanvolunteers AT parsonsnick phase1safetytrialofanaturalproductcocktailwithantibacterialactivityinhumanvolunteers AT harrisonfreya phase1safetytrialofanaturalproductcocktailwithantibacterialactivityinhumanvolunteers |